logo

For the Inventor, By the Inventor

Charlotte, NC, United States of America

Chelsea Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 70.0


Trademarks = 1

Forward Citations = 51

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Michael James Roberts (6 out of 29 patents)

silverMedal Simon Pedder (4 out of 4 patents)

bronzeMedal Ingela Fritzson (2 out of 5 patents)

4.  Ulf Vellmar (2 out of 3 patents)

5.  Stephen Peroutka (2 out of 3 patents)

6.  James Swarbrick (2 out of 3 patents)

7.  Helén Tuvesson Andersson (2 out of 2 patents)

8.  Ingrid Hallin (2 out of 2 patents)

9.  Leif Svenson (2 out of 2 patents)

10.  Gerry Rowse (1 out of 1 patent)

11.  Leif Svensson (8 patents)


10 patents:

1. 8658652 - Antifolate combinations (2014-02-25),
2. 8530653 - Enzyme inhibiting compounds (2013-09-10),
3. 8461205 - Anthranilic acid derivatives (2013-06-11),
4. 8460705 - Threo-DOPS controlled release formulation (2013-06-11),
5. 8383681 - Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders (2013-02-26),
6. 8263658 - Anthranilic acid derivatives (2012-09-11),
7. 8158149 - Threo-DOPS controlled release formulation (2012-04-17),
8. 8008285 - Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia (2011-08-30),
9. 7951812 - Substituted pyrrolo[2,3-d]pyrimidines as antifolates (2011-05-31),
10. 7829708 - Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation (2010-11-09),
Company Overview
Chelsea Therapeutics, Inc. is a biopharmaceutical company based in Charlotte, North Carolina, focused on developing innovative therapies for neurological and autoimmune disorders. The company specializes in the research and development of treatments that address unmet medical needs, particularly in conditions such as Parkinson's disease and other chronic neurological conditions. Through its commitment to advancing healthcare solutions, Chelsea Therapeutics aims to improve the quality of life for patients facing these challenging health issues.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#96 in Charlotte, NC

#621 in North Carolina

#29,892 in US

#56,119 in the World

Charlotte, NC (US)
Charlotte, NC, United States of America

Chelsea Therapeutics, Inc.

Forward Citations = 51

10 inventors:

goldMedal Michael James Roberts (6 out of 29 patents)

silverMedal Simon Pedder (4 out of 4 patents)

bronzeMedal Ingela Fritzson (2 out of 5 patents)

4.  Ulf Vellmar (2 out of 3 patents)

5.  Stephen Peroutka (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chelsea Therapeutics, Inc.. Retrieved from https://idiyas.com/company/chelsea-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…